Connecting clusters of COVID-19: an epidemiological and serological investigation.

Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

Original Publication: New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-

Betacoronavirus*; Coronavirus Infections/*epidemiology ; Coronavirus Infections/*immunology ; Immunoglobulin G/*blood ; Pneumonia, Viral/*epidemiology ; Pneumonia, Viral/*immunology; COVID-19 ; Cluster Analysis ; Contact Tracing ; Coronavirus Infections/blood ; Humans ; Immunoglobulin G/immunology ; Pandemics ; Pneumonia, Viral/blood ; Population Surveillance ; SARS-CoV-2 ; Serologic Tests ; Singapore/epidemiology

Background: Elucidation of the chain of disease transmission and identification of the source of coronavirus disease 2019 (COVID-19) infections are crucial for effective disease containment. We describe an epidemiological investigation that, with use of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological assays, established links between three clusters of COVID-19.
Methods: In Singapore, active case-finding and contact tracing were undertaken for all COVID-19 cases. Diagnosis for acute disease was confirmed with RT-PCR testing. When epidemiological information suggested that people might have been nodes of disease transmission but had recovered from illness, SARS-CoV-2 IgG serology testing was used to establish past infection.
Findings: Three clusters of COVID-19, comprising 28 locally transmitted cases, were identified in Singapore; these clusters were from two churches (Church A and Church B) and a family gathering. The clusters in Church A and Church B were linked by an individual from Church A (A2), who transmitted SARS-CoV-2 infection to the primary case from Church B (F1) at a family gathering they both attended on Jan 25, 2020. All cases were confirmed by RT-PCR testing because they had active disease, except for A2, who at the time of testing had recovered from their illness and tested negative. This individual was eventually diagnosed with past infection by serological testing. ELISA assays showed an optical density of more than 1·4 for SARS-CoV-2 nucleoprotein and receptor binding domain antigens in titres up to 1/400, and viral neutralisation was noted in titres up to 1/320.
Interpretation: Development and application of a serological assay has helped to establish connections between COVID-19 clusters in Singapore. Serological testing can have a crucial role in identifying convalescent cases or people with milder disease who might have been missed by other surveillance methods.
Funding: National Research Foundation (Singapore), National Natural Science Foundation (China), and National Medical Research Council (Singapore).
(Copyright © 2020 Elsevier Ltd. All rights reserved.)

Comment in: Lancet Infect Dis. 2020 Jul;20(7):758-759. doi: 10.1016/S1473-3099(20)30322-4. (PMID: 32330441)

Lancet. 2020 Mar 28;395(10229):1039-1046. (PMID: 32192580)
Clin Infect Dis. 2016 Feb 15;62(4):477-483. (PMID: 26565003)
Nature. 2013 Nov 28;503(7477):535-8. (PMID: 24172901)
Virus Res. 2014 Dec 19;194:175-83. (PMID: 24670324)
Am Rev Respir Dis. 1968 Aug;98(2):297-300. (PMID: 5667756)
BMJ. 2020 Feb 19;368:m627. (PMID: 32075791)
Lancet Infect Dis. 2020 Jun;20(6):689-696. (PMID: 32220650)
N Engl J Med. 2020 Mar 26;382(13):1278-1280. (PMID: 32069388)
Emerg Microbes Infect. 2020 Dec;9(1):386-389. (PMID: 32065057)
Lancet. 2003 May 24;361(9371):1767-72. (PMID: 12781535)
Sci Rep. 2019 Feb 20;9(1):2348. (PMID: 30787335)
N Engl J Med. 2020 Mar 5;382(10):970-971. (PMID: 32003551)
Science. 2005 Oct 28;310(5748):676-9. (PMID: 16195424)

0 (Immunoglobulin G)

Date Created: 20200425 Date Completed: 20200710 Latest Revision: 20240807

20240807

PMC7173813

10.1016/S1473-3099(20)30273-5

32330439